In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get an insight into how cutting edge technologies, like high-content and 3D imaging, electroporation, and validated express flow cytometry analyses help overcome challenges in CGT development.
Read More Below
Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this online symposium. We may use the information to contact you about your account and let you know about related programs and products. You may opt-out at any time. This allows Technology Networks to keep these events free of charge for our readers.
Cell and gene therapies (CGT) are a promising approach to combat previously untreatable diseases. Although the principle to enhance the body’s immune system appears obvious, successful CGT development is a demanding and lengthy process.
In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get an insight into how cutting edge technologies, like high-content and 3D imaging, electroporation, and validated express flow cytometry analyses help overcome challenges in CGT development.
Attend this event to learn:
Speakers:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2023 Technology Networks, All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy